First-in-human clinical study results

 

Cardio-microcurrent device for chronic heart failure: first-in-human clinical study

Most devices for treating ambulatory Class II and III heart failure are linked to electrical pulses. However, a steady electric potential gradient is also…

1 Min
More

Lab to market a program for researchers in Advanced Materials

 

Lab to market is a program for researchers in

Advanced Materials. If you are considering commercialising your technology, this program is for you.

We aim to turn scientists into science entrepreneurs.

 

 

Are you doing research in Advanced…

1 Min
More

The start up accelerator for advanced materials

 

The Advanced Materials Competition (AdMaCom) is a fast-paced 2 week Accelerator Program for Startups in Advanced Materials. 

AdMaCom focuses on: IP Strategy, Investment & funding opportunities, Technical & Business Mentoring, Pitch training and…

1 Min
More

Open innovation challenge for Sustainable materials solutions

Rubbers & plastics for the automotive industry

1 Min
More

SCIENION continues to grow and will build new headquarters in Berlin Adlershof

SCIENION AG, located in the Technology Park Adlershof since its foundation in 2001, today announced that the expanding company will build larger new headquarters at Wagner-Régeny Street in the same district of Berlin.

2 Min
More

GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases

• Proceeds will facilitate development of GeneQuine’s gene therapy pipeline for musculoskeletal disorders and vector platform

• Lead gene therapy candidate GQ-303, a potentially disease-modifying treatment for osteoarthritis, will be advanced to…

7 Min
More

Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1

GlycoBody to be integrated into ONK pre-clinical program ONKT103, for solid tumors.

3 Min
More

Alrise announces acquisition of its ImSus® drug delivery technology by Ferring International Center S.A.

 

The drug delivery specialist Alrise Biosystems GmbH has entered into an Asset Purchase and Exclusive License Agreement with Ferring International Center S.A. for the development and commercialisation of products manufactured with Alrise’s ImSus®…

1 Min
More

Adrenomed closes EUR 22 million equity financing to accelerate development of Adrecizumab (HAM8101) and provides business update

- Series E round led by existing top-tier life science investors Wellington Partners and HBM Healthcare Investments

- Data from AdrenOSS-2 on early treatment start with Adrecizumab in septic shock to be presented at DIVI, December 2-4, 2020

3 Min
More

COVID-19: Despite the prospect of vaccines, tests are the tool of choice

- Virologists and epidemiologists call for continuous testing to contain the pandemic

- The DiagnostikNet-BB works on many levels of the test chain

- IMDB develops new project family for comprehensive COVID-19 diagnostics

2 Min
More
Show more items